BACKGROUND: Sternal wound (SW) infection and dehiscence following median sternotomy from cardiac surgery remain difficult clinical problems with high morbidity. Older classification systems regarding timing to SW reconstruction fail to take into account recent improvements in critical care, ubiquitous usage of the wound VAC, and next-generation antibiotic therapies, which may all prolong time to reconstruction. Herein, we review our series of patients to examine timing of SW closure and resultant complications.
RESULTS:
Five hundred five patients were identified during the study period that met the above criteria, of which complete data were available on 323 who were included for analysis. Mean age at the time of surgery was 65.8 years (range, 19-90) . Twenty-four (7.4%) patients died during the study period (15 within 30 days; 4.6%). The 3 groups included 13, 148, and 162 patients with the mean time to SW surgery of 3.8, 17.2, and 63.0 days, respectively. Postdebridement cultures were positive in 3 (23.1%), 70 (47.3%), and 85 (52.5%; P = 0.23), and rates of postoperative infection were significantly different: 0%, 0.7%, and 8.0% (P = 0.01). Rates of extubation while in the operating room were 28.6%, 54.9%, and 84.5% (P < 0.01). Seroma rates were 0%, 7.4%, and 3.7%; hematomas were 0%, 2.0%, and 1.9%; partial wound dehiscence was 7.7%, 0.7%, and 11.1%. There were no significant differences in need for subsequent SW reoperations (7.7%, 6.8%, and 8.6%; P = 0.13). Median postoperative length of stay was 20, 16, and 7 days (P = 0.03), and median time to drain removal was 27.5, 24, and 19.5 days (P = 0.56). Postoperative death was seen in 15.4%, 6.1%, and 8.0% (P = 0.28).
CONCLUSIONS:
In this large series of over 500 cases of SW reconstruction, we find that delayed reconstruction >30 days is associated with a significantly elevated infection rate. Yet, this same delayed group >30 days following the initial cardiac surgery procedure had the shortest postoperative length of stay and was most likely to be extubated in the operating room. Further studies are necessary to delineate optimal timing of reconstruction. The labia majora are the embryologic homolog of the scrotum, making it the ideal donor tissue for neoscrotoplasty. The flap blood supply is derived from the pudendal vascular system. Detailed review of the flap harvest technique (first mentioned by Monstrey et al 1 ) and analysis of the outcomes of labia majora flap scrotoplasty and perineal reconstruction will help providers better understand and care for transmasculine patients who have had genital surgery.
Labia Majora Flap Scrotoplasty and Perineal Reconstruction in Phalloplasty

METHODS:
We retrospectively reviewed the outcomes of phalloplasty patients who underwent either primary or secondary labia majora flap scrotoplasty and perineal reconstruction from October 1, 2017, to October 1, 2018. Bilateral elevation, rotation, and flap advancement from the posterior to anterior position formed a pouch-like scrotum. Scrotoplasty was followed by multilayered closure of the resultant perineal wound with apposition of the inner thigh skin to complete the perineal reconstruction.
RESULTS:
The mean follow-up was 7 months (0.5-12 months). Out of the 60 total scrotoplasty patients, 47 had labia majora flap scrotoplasty and perineal reconstruction at the time of phalloplasty. The remaining 13 underwent scrotoplasty secondarily. Unilateral distal flap necrosis occurred in 3 patients (5%); all 3 were ipsilateral to the groin dissection required for phalloplasty. Wound dehiscence was observed at the perineoscrotal junction and along the perineal closure in 11 patients (18%) and 1 patient (1.7%), respectively. All wounds were managed conservatively and healed well except for 3 patients who developed urethrocutaneous fistulas at the perineoscrotal junction site. Two of the 3 patients also had fistulas at the midline anterior scrotum and a concomitant urethral anastomotic stricture. All 3 patients required fistula repair, and 2 required urethroplasty. The patient who had a perineal wound dehiscence also had a perineal hematoma, a perineal urethrocutaneous fistula, and a urethral stricture. No scrotal hematomas were seen.
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BACKGROUND: We describe the technique of robotic vaginectomy, anterior vaginal flap urethroplasty, and the use of a longitudinally split pedicled gracilis muscle flap to recreate the bulbar urethra and help fill the vaginal defect in female-to-male gender affirming phalloplasty.
METHODS:
Vaginectomy is performed via robotic-assisted laparoscopic transabdominal approach. Concurrently, gracilis muscle is harvested and passed through a tunnel between the groin and vaginal cavity. It is then split longitudinally and the inferior half is passed into the vaginal cavity, where it is inset into the vaginal cavity. Following urethroplasty, the superior half of the gracilis flap is placed around the vaginal flap to buttress this suture line with well-vascularized tissue.
RESULTS:
From May 2016 to March 2018, 16 patients underwent this procedure, of average age 35.1 ± 8.8 years, body mass index 31.4 ± 5.5, and American Society of Anesthesiologists class 1.8 ± 0.6. The average length of operation was 423.6 ± 84.6 minutes, with an estimated blood loss of 246.9 ± 84.9 ml. Patients were generally out of bed on postoperative day 1, ambulating on postoperative day 2, and discharged home on postoperative day 3 (average day of discharge, 3.4 ± 1.4 days). At mean follow-up time of 361.1 ± 175.5 days, no patients developed urinary fistula at the urethroplasty site.
CONCLUSIONS:
Our use of the longitudinally split gracilis muscle in first-stage phalloplasty represents a novel approach to providing well-vascularized tissue to achieve both urethral support and closure of intra-pelvic dead space, with a single flap, in a safe, efficient, and reproducible manner. We assessed insurance coverage of "top" gender-affirming surgery and evaluated the differences between insurance policy criteria and WPATH recommendations.
METHODS:
We conducted a cross-sectional analysis of insurance policies for coverage of top gender-affirming surgery. Insurance companies were selected based on their state enrolment data and market share. A web-based search and individual telephone interviews were conducted to identify the policy. Medical necessity criteria were abstracted from publicly available policies.
RESULTS:
Of the 57 insurers evaluated, bilateral mastectomy (female-to-male) was covered by significantly more insurers than breast augmentation (male-to-female) (96% versus 68%; P < 0.0001). Only 4% of companies used WPATH-consistent criteria. No criterion was universally required by insurers. Additional prerequisites for coverage that extended beyond WPATH guidelines for top surgery were continuous living in congruent gender role, 2 referring mental health professionals, and hormone therapy before surgery. Hormone therapy was required in a significantly higher proportion of male-to-female policies compared to female-to-male policies (90% versus 21%; P < 0.0001).
CONCLUSION:
In addition to the marked intercompany variation in criteria for insurance coverage which often deviated from WPATH recommendations, there are healthcare insurers who categorically deny access to top gender-affirming surgery. A greater evidence base is
